Progressive familial intrahepatic cholestasis type 1

Seminars in Liver Disease

Volumn 30, Issue 2, 2010, Pages 117-124

  Paulusma, Coen C ^a   Elferink, Ronald P J Oude ^a   Jansen, Peter L M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

ATP8B1; Benign recurrent intrahepatic cholestasis; Bile salt export pump; Farnesoid X receptor; Intrahepatic cholestasis of pregnancy; Partial external biliary diversion; Progressive familial intrahepatic cholestasis

Indexed keywords

BILE SALT; GAMMA GLUTAMYLTRANSFERASE; PHOSPHATIDYLSERINE; PROTEIN; PROTEIN ATP8B1; UNCLASSIFIED DRUG;

ATP8B1 GENE; ENZYME ACTIVITY; GENE; GENE EXPRESSION; GENE MUTATION; HAIR CELL; HEARING LOSS; HUMAN; INTRAHEPATIC CHOLESTASIS; JAUNDICE; LIPID TRANSPORT; NONHUMAN; PRIORITY JOURNAL; PRURITUS; REVIEW;

ADENOSINE TRIPHOSPHATASES; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BILE ACIDS AND SALTS; BILIARY TRACT SURGICAL PROCEDURES; CHOLESTASIS, INTRAHEPATIC; DISEASE PROGRESSION; GALLBLADDER; HUMANS; MUTATION; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECURRENCE;

EID: 77951605336     PISSN: 02728087     EISSN: 10988971     Source Type: Journal    
DOI: 10.1055/s-0030-1253221     Document Type: Review

References (48)

1. Davit-Spraul A, Gonzales E, Baussan C, Jacquemin E. Progressive familial intrahepatic cholestasis. Orphanet J Rare Dis 2009 4 1
2. Bull L N., van Eijk M J., Pawlikowska L et al. A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis. Nat Genet 1998 18 (3) 219-224
3. Bull L N., Juijn J A., Liao M et al. Fine-resolution mapping by haplotype evaluation: the examples of PFIC1 and BRIC. Hum Genet 1999 104 (3) 241-248
4. Klomp L W., Bull L N., Knisely A S. et al. A missense mutation in FIC1 is associated with greenland familial cholestasis. Hepatology 2000 32 (6) 1337-1341
5. Eppens E F., van Mil S W., de Vree J M. et al. FIC1, the protein affected in two forms of hereditary cholestasis, is localized in the cholangiocyte and the canalicular membrane of the hepatocyte. J Hepatol 2001 35 (4) 436-443
6. van Mil S W., van Oort M M., van den Berg I E., Berger R, Houwen R H., Klomp L W. FIC1 is expressed at apical membranes of different epithelial cells in the digestive tract and is induced in the small intestine during postnatal development of mice. Pediatr Res 2004 56 (6) 981-987
7. Klomp L W., Vargas J C., van Mil S W. et al. Characterization of mutations in ATP8B1 associated with hereditary cholestasis. Hepatology 2004 40 (1) 27-38
8. Oshima T, Ikeda K, Takasaka T. Sensorineural hearing loss associated with Byler disease. Tohoku J Exp Med 1999 187 (1) 83-88
9. Bull L N., Carlton V E., Stricker N L. et al. Genetic and morphological findings in progressive familial intrahepatic cholestasis (Byler disease [PFIC-1] and Byler syndrome): evidence for heterogeneity. Hepatology 1997 26 (1) 155-164
10. Bustorff-Silva J, Sbraggia Neto L, Olmpio H et al. Partial internal biliary diversion through a cholecystojejunocolonic anastomosisa novel surgical approach for patients with progressive familial intrahepatic cholestasis: a preliminary report. J Pediatr Surg 2007 42 (8) 1337-1340
11. Egawa H, Yorifuji T, Sumazaki R, Kimura A, Hasegawa M, Tanaka K. Intractable diarrhea after liver transplantation for Byler's disease: successful treatment with bile adsorptive resin. Liver Transpl 2002 8 (8) 714-716
12. Tygstrup N, Steig B A., Juijn J A., Bull L N., Houwen R H. Recurrent familial intrahepatic cholestasis in the Faeroe Islands. Phenotypic heterogeneity but genetic homogeneity. Hepatology 1999 29 (2) 506-508
13. Lykavieris P, van Mil S, Cresteil D et al. Progressive familial intrahepatic cholestasis type 1 and extrahepatic features: no catch-up of stature growth, exacerbation of diarrhea, and appearance of liver steatosis after liver transplantation. J Hepatol 2003 39 (3) 447-452
14. Miyagawa-Hayashino A, Egawa H, Yorifuji T et al. Allograft steatohepatitis in progressive familial intrahepatic cholestasis type 1 after living donor liver transplantation. Liver Transpl 2009 15 (6) 610-618
15. van Berge Henegouwen G P., Brandt K H., de Pagter A G. Is an acute disturbance in hepatic transport of bile-acids the primary cause of cholestasis in benign recurrent intrahepatic cholestasis? Lancet 1974 1 (7869) 1249-1251
16. Schmeisser W, Eggstein M, Maulbetsch R, Dlle W. [A case of benign recurring intrahepatic cholestasis (Tygstrup-Summerskill and Walshe syndrome)]. Schweiz Med Wochenschr 1977 107 (45) 1613-1620
17. Stapelbroek J M., van Erpecum K J., Klomp L W. et al. Nasobiliary drainage induces long-lasting remission in benign recurrent intrahepatic cholestasis. Hepatology 2006 43 (1) 51-53
18. de Pagter A G., van Berge Henegouwen G P., ten Bokkel Huinink J A., Brandt K H. Familial benign recurrent intrahepatic cholestasis. Interrelation with intrahepatic cholestasis of pregnancy and from oral contraceptives? Gastroenterology 1976 71 (2) 202-207
19. Mllenbach R, Bennett A, Tetlow N et al. ATP8B1 mutations in British cases with intrahepatic cholestasis of pregnancy. Gut 2005 54 (6) 829-834
20. Folmer D E., Elferink R P., Paulusma C C. P4 ATPases - lipid flippases and their role in disease. Biochim Biophys Acta 2009 1791 (7) 628-635
21. Holthuis J C., Levine T P. Lipid traffic: floppy drives and a superhighway. Nat Rev Mol Cell Biol 2005 6 (3) 209-220
22. Zachowski A. Phospholipids in animal eukaryotic membranes: transverse asymmetry and movement. Biochem J 1993 294 (Pt 1) 1-14
23. Devaux P F., Lpez-Montero I, Bryde S. Proteins involved in lipid translocation in eukaryotic cells. Chem Phys Lipids 2006 141 (1-2) 119-132
24. Paulusma C C., Oude Elferink R P. Diseases of intramembranous lipid transport. FEBS Lett 2006 580 (23) 5500-5509
25. Ujhazy P, Ortiz D, Misra S et al. Familial intrahepatic cholestasis 1: studies of localization and function. Hepatology 2001 34 (4 Pt 1) 768-775
26. Paulusma C C., Folmer D E., Ho-Mok K S. et al. ATP8B1 requires an accessory protein for endoplasmic reticulum exit and plasma membrane lipid flippase activity. Hepatology 2008 47 (1) 268-278
27. Cai S Y., Gautam S, Nguyen T, Soroka C J., Rahner C, Boyer J L. ATP8B1 deficiency disrupts the bile canalicular membrane bilayer structure in hepatocytes, but FXR expression and activity are maintained. Gastroenterology 2009 136 (3) 1060-1069
28. Nibbering C P., Groen A K., Ottenhoff R, Brouwers J F., vanBerge-Henegouwen G P., van Erpecum K J. Regulation of biliary cholesterol secretion is independent of hepatocyte canalicular membrane lipid composition: a study in the diosgenin-fed rat model. J Hepatol 2001 35 (2) 164-169
29. Amigo L, Mendoza H, Zanlungo S et al. Enrichment of canalicular membrane with cholesterol and sphingomyelin prevents bile salt-induced hepatic damage. J Lipid Res 1999 40 (3) 533-542
30. Oude Elferink R PJ, Paulusma C C., Groen A K. Hepatocanalicular transport defects: pathophysiologic mechanisms of rare diseases. Gastroenterology 2006 130 (3) 908-925
31. Pawlikowska L, Groen A, Eppens E F. et al. A mouse genetic model for familial cholestasis caused by ATP8B1 mutations reveals perturbed bile salt homeostasis but no impairment in bile secretion. Hum Mol Genet 2004 13 (8) 881-892
32. Paulusma C C., Groen A, Kunne C et al. ATP8B1 deficiency in mice reduces resistance of the canalicular membrane to hydrophobic bile salts and impairs bile salt transport. Hepatology 2006 44 (1) 195-204
33. Groen A, Kunne C, Jongsma G et al. ABCG5/8 independent biliary cholesterol excretion in ATP8B1-deficient mice. Gastroenterology 2008 134 (7) 2091-2100
34. Paulusma C C., de Waart D R., Kunne C, Mok K S., Elferink R P. Activity of the bile salt export pump (ABCB11) is critically dependent on canalicular membrane cholesterol content. J Biol Chem 2009 284 (15) 9947-9954
35. Alvarez L, Jara P, Snchez-Sabat E et al. Reduced hepatic expression of farnesoid X receptor in hereditary cholestasis associated to mutation in ATP8B1. Hum Mol Genet 2004 13 (20) 2451-2460
36. Chen F, Ananthanarayanan M, Emre S et al. Progressive familial intrahepatic cholestasis, type 1, is associated with decreased farnesoid X receptor activity. Gastroenterology 2004 126 (3) 756-764
37. Chen F, Ellis E, Strom S C., Shneider B L. ATPase class I type 8B member 1 and protein kinase C zeta induce the expression of the canalicular bile salt export pump in human hepatocytes. Pediatr Res 2010 67 (2) 183-187
38. Frankenberg T, Miloh T, Chen F Y. et al. The membrane protein ATPase class I type 8B member 1 signals through protein kinase C zeta to activate the farnesoid X receptor. Hepatology 2008 48 (6) 1896-1905
39. Koh S, Takada T, Kukuu I, Suzuki H. FIC1-mediated stimulation of FXR activity is decreased with PFIC1 mutations in HepG2 cells. J Gastroenterol 2009 44 (6) 592-600
40. Martnez-Fernndez P, Hierro L, Jara P, Alvarez L. Knockdown of ATP8B1 expression leads to specific downregulation of the bile acid sensor FXR in HepG2 cells: effect of the FXR agonist GW4064. Am J Physiol Gastrointest Liver Physiol 2009 296 (5) G1119-G1129
41. Demeilliers C, Jacquemin E, Barbu V et al. Altered hepatobiliary gene expressions in PFIC1: ATP8B1 gene defect is associated with CFTR downregulation. Hepatology 2006 43 (5) 1125-1134
42. Inagaki T, Choi M, Moschetta A et al. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab 2005 2 (4) 217-225
43. Folmer D E., van der Mark V A., Ho-Mok K S., Oude Elferink R P., Paulusma C C. Differential effects of progressive familial intrahepatic cholestasis type 1 and benign recurrent intrahepatic cholestasis type 1 mutations on canalicular localization of ATP8B1. Hepatology 2009 50 (5) 1597-1605
44. van der Velden L M., Stapelbroek J M., Krieger E et al. Folding defects in P-type ATP 8B1 associated with hereditary cholestasis are ameliorated by 4-phenylbutyrate. Hepatology 2010 51 (1) 286-296
45. Elferink M G., Olinga P, Draaisma A L. et al. LPS-induced downregulation of MRP2 and BSEP in human liver is due to a posttranscriptional process. Am J Physiol Gastrointest Liver Physiol 2004 287 (5) G1008-G1016
46. Geier A, Dietrich C G., Voigt S et al. Cytokine-dependent regulation of hepatic organic anion transporter gene transactivators in mouse liver. Am J Physiol Gastrointest Liver Physiol 2005 289 (5) G831-G841
47. Siewert E, Dietrich C G., Lammert F et al. Interleukin-6 regulates hepatic transporters during acute-phase response. Biochem Biophys Res Commun 2004 322 (1) 232-238
48. Stapelbroek J M., Peters T A., van Beurden D H. et al. ATP8B1 is essential for maintaining normal hearing. Proc Natl Acad Sci U S A 2009 106 (24) 9709-9714